Jeffery W Chambers MD Appointed CMO of Cardiovascular Systems

Jeffery W Chambers MD is the new Chief Medical Officer at Cardiovascular Systems.

“CSI is developing an exciting product pipeline that targets some of the fastest growing segments of interventional cardiology,” said Scott Ward, Chairman, President and Chief Executive Officer. “Jeff brings contemporary interventional cardiology practice and extensive clinical research experience to CSI as we seek to expand our product offering beyond orbital atherectomy. We believe Jeff brings valuable perspective to CSI as we seek to successfully develop and commercialize everolimus drug coated balloons, intravascular lithotripsy balloons, thrombectomy devices and mechanical circulatory support products.”

Said Chambers, “I am excited to join CSI and I look forward to working with the team to bring innovative and important technologies to underserved patient populations. In doing so, together, we will improve the health of people with coronary and peripheral artery disease and fulfill our Mission.”

Jeffrey W Chambers MD was the primary investigator for the ORBIT II study, which served as the pivotal trial supporting the premarket approval for the use of orbital atherectomy in coronary arteries. In addition, he has served as a consultant in connection with CSI’s product development, quality assurance, medical affairs and clinical research.

Dr. Chambers received his medical degree from Wayne State University and completed his residency in Internal Medicine and fellowships in cardiovascular disease and interventional cardiology at the University of Minnesota. He has been employed at the Metropolitan Heart and Vascular Institute since 1995. Dr. Chambers is a serial entrepreneur with numerous issued patents, some of which are associated with devices commercially available today. He is a Fellow at The American College of Cardiology and is a member of The Society for Cardiovascular Angiography and Interventions.

Other Executives In the News

Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr. Val Kolesnitchenko brings extensive ophthalmology experience in clinical practice and industry to new therapeutics for the aging eye.
These strategic appointments signify a significant milestone for BRIJ Medical as they usher in a new era of post-surgical and trauma incision care with proven technologies that minimize wound complications and scarring.
Dr. Eckhard von Keutz has extensive experience in designing and conducting preclinical/toxicological studies, and toxicological risk assessment and management.
David Kroekel has more than 35 years of experience in medical device, combination product operations, and product development.
Dr. Konstantin Kousoulas, a leading virologist will work to further Rational Vaccines core mission of eradicating the world of the herpes simplex virus. "Dr. Kousoulas...

By using this website you agree to accept Medical Device News Magazine Privacy Policy